Clinical Trial

A Study to Evaluate the Efficacy and Safety of Veverimer for the Treatment of Metabolic Acidosis

Name: A Study to Evaluate the Efficacy and Safety of Veverimer for the Treatment of Metabolic Acidosis — clinical trial record (NCT07355062)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 3

View on ClinicalTrials.gov →

Summary

The purpose of this study is is to evaluate the efficacy and safety of veverimer in treating adults with moderate-to-severe chronic kidney disease (CKD) and metabolic acidosis.

Protocol Amendment History 1 change

notable Trial sites expanded: 9 -> 14 locations 2026-04-03

Trial Details

NCT Number	NCT07355062
Lead Sponsor	Renibus Therapeutics, Inc.
Conditions	CKD, Metabolic Acidosis
Enrollment	150 participants
Start Date	2026-01-13
Primary Completion	2027-06 (estimated)
Study Completion	2027-06 (estimated)
Updated on ClinicalTrials.gov	2026-07-28